Increased Susceptibility to Doxorubicin-Induced Cell Death in Acute Lymphocytic Leukemia Cells by Inhibiting Serine/Threonine WEE1 Kinase Expression
Abbas Ali Hosseinpour Feizi(Tabriz University of Medical Sciences), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Mehdi yusefi(Tabriz University of Medical Sciences), Sepideh Izadi(German Cancer Research Center), Sara Adibfar(Kermanshah University of Medical Sciences), Vahid Karpisheh(Tabriz University of Medical Sciences), Ali Akbar Movassaghpour, Sajjad Vakili‐Samiani(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Saeed Solali(Tabriz University of Medical Sciences), omid judi khanghah(Tabriz University of Medical Sciences), Fatemeh Atyabi(Tehran University of Medical Sciences)
Cited by 0
Related Papers
CAR T cells in solid tumors: challenges and opportunities
|Stem Cell Research & Therapy|2021|573
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202